Next 10 |
2024-04-01 04:15:02 ET Ascendiant analyst issues BUY recommendation for BIOL on April 1, 2024 03:05AM ET. The previous analyst recommendation was Buy. BIOL was trading at $0.1898 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 r...
2024-03-25 06:09:00 ET 3 Future Penny Stocks Investing Trends to Consider in 2024 Penny stocks represent a unique segment of the market, offering high potential returns to investors willing to navigate its volatility. Trading penny stocks in 2024 requires an understanding of emerging tr...
2024-03-23 06:21:00 ET 3 Top Pros to Consider for Investing in Penny Stocks Penny stocks represent a unique opportunity for investors looking to expand their portfolios with potentially high-reward investments. Characterized by their low price per share, typically less than five dollars...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 4.2% to $0.1248 on volume of 179,379,334 shares Biolase Inc. (BIOL) rose 19.5% to $0.1793 on volume of 129,349,610 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 0.6% to $3.22 on volume o...
A look at the top 10 most actives in the United States Biolase Inc. (BIOL) rose 52.0% to $0.228 on volume of 76,448,685 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 8.5% to $0.1476 on volume of 32,191,096 shares Nova Lifestyle Inc (NVFY) rose 121.6% to $4.1 on volume of 32,...
2024-03-22 07:03:55 ET DENVER, Colo., Mar 22, 2024 ( 247marketnews.com )- BIOLASE, Inc. (NASDAQ: BIOL ) reported, after yesterday’s market close, its fourth quarter and full year 2023 financial results. BIOLASE achieved revenue growth in 2023, to $49.2 million, an increas...
2024-03-21 18:35:02 ET BIOLASE, Inc. (BIOL) Q4 2023 Earnings Call Transcript March 21, 2024, 04:30 PM ET Company Participants Todd Kehrli - IR, EVC Group John Beaver - President and CEO Jennifer Bright - CFO Conference Call Participants Bruce Jackson ...
2024-03-21 16:15:05 ET More on Biolase BIOLASE announces pricing of $7 million public offering Seeking Alpha’s Quant Rating on Biolase Historical earnings data for Biolase Financial information for Biolase Read the full article on Seeking Alp...
LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, who previously announced its preliminary financial results for the fourth quarter and full year ended December 31, 2023, today reported its financial results ...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
News, Short Squeeze, Breakout and More Instantly...
2024-04-01 04:15:02 ET Ascendiant analyst issues BUY recommendation for BIOL on April 1, 2024 03:05AM ET. The previous analyst recommendation was Buy. BIOL was trading at $0.1898 at issue of the analyst recommendation. Historical Analyst Recommendations Latest 10 r...
2024-03-25 06:09:00 ET 3 Future Penny Stocks Investing Trends to Consider in 2024 Penny stocks represent a unique segment of the market, offering high potential returns to investors willing to navigate its volatility. Trading penny stocks in 2024 requires an understanding of emerging tr...
2024-03-23 06:21:00 ET 3 Top Pros to Consider for Investing in Penny Stocks Penny stocks represent a unique opportunity for investors looking to expand their portfolios with potentially high-reward investments. Characterized by their low price per share, typically less than five dollars...